Novartis Ag NVS
NYSE NVS
$150.59 +0.21 (+0.14%)
As of: Oct 16, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Sales of Property, Plant and Equipment (2009 - 2026)

Updated

Novartis Ag's Sales of Property, Plant and Equipment was $49 million in Q2 2026, up 145.0% from $20 million a year earlier and up 32.4% from the prior quarter.

Analysis

Novartis Ag (NVS) Sales of Property, Plant and Equipment (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Novartis Ag's Sales of Property, Plant and Equipment was $250 million through Jun 30, 2026, down 14.4% year-over-year; for FY2025, it came in at $209 million, down 78.2% from FY2024.

  • Sales of Property, Plant and Equipment shows a five-year compound annual growth rate of -10.3% (FY2020 to FY2025).
  • In earlier years, Sales of Property, Plant and Equipment was $957 million in FY2024 (+175.0%), $348 million in FY2023 (+161.7%), $133 million in FY2022 (-69.8%) and $440 million in FY2021 (+22.6%).
  • Quarterly Sales of Property, Plant and Equipment has moved between -$20 million (Q3 2021) and $647 million (Q2 2024) over five years.
  • Compared with a year earlier, Sales of Property, Plant and Equipment has increased for three straight quarters, with growth averaging 9.3% over the last eight quarters.
  • The best year-over-year quarter for Sales of Property, Plant and Equipment over five years was Q3 2023 (growth of 250.0%); the worst was Q2 2025 (a decline of 96.9%).
  • Per Business Quant data, NVS's Sales of Property, Plant and Equipment in the three quarters before Q2 2026 was $37 million (Q1 2026), $24 million (Q4 2025) and $140 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 63.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 26.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 4.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.00 Mn
Mar 31, 2026 5.00 Mn
Dec 31, 2025 1.00 Mn
Sep 30, 2025 1.00 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 10.00 Mn
Dec 31, 2024 47.00 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 37.00 Mn
Mar 31, 2024 1.00 Mn
Dec 31, 2023 164.00 Mn
Sep 30, 2023 51.00 Mn
Jun 30, 2023 4.00 Mn
Mar 31, 2023 18.00 Mn
Dec 31, 2022 102.00 Mn
Sep 30, 2022 20.00 Mn
Jun 30, 2022 13.00 Mn
Mar 31, 2022 33.00 Mn
Dec 31, 2021 74.00 Mn
Sep 30, 2021 81.00 Mn
API Access

Novartis Ag Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=NVS&period=max&api_key=YOUR_API_KEY